Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy.
about
Pazopanib and HDAC inhibitors interact to kill sarcoma cells.Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.PDE5 inhibitors enhance celecoxib killing in multiple tumor types.Nexavar/Stivarga and viagra interact to kill tumor cells.MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features.HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cellsLapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanisms.How do tumor cells respond to HDAC inhibition?
P2860
Q33631472-8F8898CE-E6A2-4B90-BB71-2BC8AB83FB16Q34276149-E9B432F6-38EE-43EB-9239-CC5CB61225EFQ34289307-84CAF1C2-3D91-47D3-B1CA-76E0506E0ED3Q35430943-1C1FFC41-3620-405D-939C-8E9CB3E8A30AQ36808335-C64073D5-CD9D-4496-91D0-849E286EB25FQ37457859-F30A01E4-3114-4F9F-8936-7D674D778405Q37683049-B93DD0B7-6DBF-496A-A5D3-C60A99E2684CQ38812867-19A1D3E3-9DD6-4309-95A2-89AB7EF9356CQ38817005-5B7CADF0-D4D8-4DCA-A730-BFE105A57A50
P2860
Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Histone deacetylase inhibitors ...... e to anti-ERBB1/ERBB2 therapy.
@en
Histone deacetylase inhibitors ...... e to anti-ERBB1/ERBB2 therapy.
@nl
type
label
Histone deacetylase inhibitors ...... e to anti-ERBB1/ERBB2 therapy.
@en
Histone deacetylase inhibitors ...... e to anti-ERBB1/ERBB2 therapy.
@nl
prefLabel
Histone deacetylase inhibitors ...... e to anti-ERBB1/ERBB2 therapy.
@en
Histone deacetylase inhibitors ...... e to anti-ERBB1/ERBB2 therapy.
@nl
P2093
P2860
P356
P1476
Histone deacetylase inhibitors ...... e to anti-ERBB1/ERBB2 therapy.
@en
P2093
Andrew Poklepovic
Gangadharan B Sajithlal
Hossein A Hamed
Jahangir Syed
Laurence Booth
Nichola Cruickshanks
Seyedmehrad Tavallai
Steven Grant
P2860
P304
P356
10.4161/CBT.26234
P50
P577
2013-08-22T00:00:00Z